Landscapes / Companies
FutureGen Biopharmaceutical (Beijing) Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 2 checked
Trials
5 active
6 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
M108not checked |
— |
Phase 3 | 11 Jan 2027Phase 3 trial completes | ||
| Next date | 11 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Locally Advanced Unresectable or Metastatic Gastric Cancer, Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Claudin 18.2 and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2031Phase 1/2 trial completes | |||
| Next date | Jan 2031 · Phase 1/2 trial completes | ||||
| Also tested for | PTCL, TRBC1 ADC and 1 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021